Christopher Longshaw

Author

Also Known As

C. Longshaw, C. M. Longshaw, C.M. Longshaw, Chris Longshaw, Chris M Longshaw, Chris M. Longshaw, Christopher Longshaw, Christopher M Longshaw, Christopher M. Longshaw, Georgina Davis

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Astellas Pharma (United Kingdom)University of Leeds Leeds Teaching Hospitals NHS Trust Shionogi (Japan)Centro de Investigación Biomédica en Red

About

Christopher Longshaw is an author at Astellas Pharma (United Kingdom) specializing in clinical microbiology, medicine, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Epidemiology	3	3	738
3	Engineering	1	1	89
4	Health Sciences	1	1	44
5	Public Health	1	1	340

Christopher Longshaw

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID) Kerrie Davies, Christopher Longshaw, Georgina Davis, The Lancet Infectious Diseases AntibioticsClostridium DifficileClostridium Difficile InfectionHealthcare-associated InfectionTraveler Diarrhea	2014	340
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes Jane Freeman, Jon J. Vernon, K. Morris, Clinical Microbiology and Infection Antimicrobial Resistance GeneAntimicrobial SusceptibilityAntibioticsPan-european Longitudinal SurveillanceAntimicrobial Therapy	2014	264
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila, The Lancet Infectious Diseases Patients 60Antimicrobial SusceptibilityAntibioticsClostridium Difficile InfectionAntimicrobial Chemotherapy	2017	208
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013 Kerrie Davies, Helen Ashwin, Christopher Longshaw, Eurosurveillance	2016	178
The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014 Jane Freeman, Jon J. Vernon, Sally Pilling, Clinical Microbiology and Infection Antimicrobial SusceptibilityAntibioticsMedicineMicrobiologyInfection Control	2017	134
Unsaturated fatty acids are inhibitors of bacterial conjugation Raúl Fernández-López, Cristina Machón, Christopher Longshaw, Microbiology	2005	125
Is the GehD Lipase from Staphylococcus epidermidis a Collagen Binding Adhesin? M. Gabriela Bowden, Livia Visai, Christopher Longshaw, Journal of Biological Chemistry	2002	117
Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases The GenBank accession number for the nucleotide sequence determined in this work is AF090142. Christopher Longshaw, Angela Farrell, John D. Wright, Microbiology Unidentified LipaseGehd GenesEngineeringMedicineStaphylococcus Epidermidis	2000	89
Antibiotic research and development: business as usual? Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett, Journal of Antimicrobial Chemotherapy	2015	83
Kytococcus sedentarius, the organism associated with pitted keratolysis, produces two keratin-degrading enzymes Christopher Longshaw, John D. Wright, Angela Farrell, Journal of Applied Microbiology	2002	75

Page 1